These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12239596)

  • 1. The HMG-CoA reductase inhibitor lovastatin protects cells from the antineoplastic drugs doxorubicin and etoposide.
    Bardeleben RV; Dunkern T; Kaina B; Fritz G
    Int J Mol Med; 2002 Oct; 10(4):473-9. PubMed ID: 12239596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.
    Damrot J; Nübel T; Epe B; Roos WP; Kaina B; Fritz G
    Br J Pharmacol; 2006 Dec; 149(8):988-97. PubMed ID: 17088865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
    Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
    Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
    Choi JW; Jung SE
    J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the HMG-CoA reductase inhibitor lovastatin and nitric oxide in cardiomyocyte cell death.
    Rabkin SW; Tsang MY
    Pharmacology; 2008; 82(1):74-82. PubMed ID: 18504415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks.
    Nübel T; Damrot J; Roos WP; Kaina B; Fritz G
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):933-9. PubMed ID: 16467108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
    Kim W; Yoon JH; Kim JR; Jang IJ; Bang YJ; Kim YJ; Lee HS
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):497-507. PubMed ID: 19096848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells.
    Noguchi M; Kabayama K; Uemura S; Kang BW; Saito M; Igarashi Y; Inokuchi J
    Glycobiology; 2006 Jul; 16(7):641-50. PubMed ID: 16571667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho GTPases: promising cellular targets for novel anticancer drugs.
    Fritz G; Kaina B
    Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
    Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
    Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK; Schadendorf D; Röckmann H
    Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionizing radiation-induced E-selectin gene expression and tumor cell adhesion is inhibited by lovastatin and all-trans retinoic acid.
    Nübel T; Dippold W; Kaina B; Fritz G
    Carcinogenesis; 2004 Aug; 25(8):1335-44. PubMed ID: 14988223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
    Hoque A; Chen H; Xu XC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo.
    Ostrau C; Hülsenbeck J; Herzog M; Schad A; Torzewski M; Lackner KJ; Fritz G
    Radiother Oncol; 2009 Sep; 92(3):492-9. PubMed ID: 19615773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
    Song CY; Kim BC; Lee HS
    Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.
    Reske SN; Deisenhofer S; Glatting G; Zlatopolskiy BD; Morgenroth A; Vogg AT; Buck AK; Friesen C
    J Nucl Med; 2007 Jun; 48(6):1000-7. PubMed ID: 17504875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.